ZA986893B - Oral pharmaceutical preparation which includes a compound of anti-ulcer activity and procedure for making same - Google Patents
Oral pharmaceutical preparation which includes a compound of anti-ulcer activity and procedure for making sameInfo
- Publication number
- ZA986893B ZA986893B ZA986893A ZA986893A ZA986893B ZA 986893 B ZA986893 B ZA 986893B ZA 986893 A ZA986893 A ZA 986893A ZA 986893 A ZA986893 A ZA 986893A ZA 986893 B ZA986893 B ZA 986893B
- Authority
- ZA
- South Africa
- Prior art keywords
- procedure
- compound
- pharmaceutical preparation
- oral pharmaceutical
- making same
- Prior art date
Links
- 230000000767 anti-ulcer Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 239000008183 oral pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009701816A ES2137862B1 (es) | 1997-07-31 | 1997-07-31 | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA986893B true ZA986893B (en) | 1999-01-27 |
Family
ID=8300432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA986893A ZA986893B (en) | 1997-07-31 | 1998-07-31 | Oral pharmaceutical preparation which includes a compound of anti-ulcer activity and procedure for making same |
Country Status (33)
Country | Link |
---|---|
US (1) | US20020098242A1 (xx) |
EP (1) | EP1010423B1 (xx) |
JP (1) | JP3961217B2 (xx) |
KR (1) | KR100591488B1 (xx) |
AR (1) | AR013242A1 (xx) |
AT (1) | ATE317688T1 (xx) |
AU (1) | AU751609B2 (xx) |
BG (1) | BG64967B1 (xx) |
CA (1) | CA2307037C (xx) |
CR (1) | CR5826A (xx) |
CZ (1) | CZ298700B6 (xx) |
DE (1) | DE69833490T2 (xx) |
DK (1) | DK1010423T3 (xx) |
ES (3) | ES2137862B1 (xx) |
GT (1) | GT199800113A (xx) |
HN (1) | HN1998000113A (xx) |
HR (1) | HRP20000053B1 (xx) |
HU (1) | HU230635B1 (xx) |
IL (1) | IL134158A (xx) |
MY (1) | MY121353A (xx) |
NO (1) | NO20000435L (xx) |
NZ (1) | NZ502590A (xx) |
PA (1) | PA8456401A1 (xx) |
PE (1) | PE105199A1 (xx) |
PL (1) | PL192961B1 (xx) |
PT (1) | PT1010423E (xx) |
RU (1) | RU2207114C2 (xx) |
SK (1) | SK284892B6 (xx) |
TR (1) | TR200000264T2 (xx) |
TW (1) | TW533201B (xx) |
UA (1) | UA66800C2 (xx) |
WO (1) | WO1999006032A2 (xx) |
ZA (1) | ZA986893B (xx) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
US6228400B1 (en) * | 1999-09-28 | 2001-05-08 | Carlsbad Technology, Inc. | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
AU2002225763A1 (en) | 2000-11-28 | 2002-06-11 | Fmc Corporation | Edible pga(propylene glycol alginate) coating composition |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
KR100447085B1 (ko) * | 2001-11-08 | 2004-09-04 | 바램제약주식회사 | 마그네슘이온, 칼슘이온 또는 철이온이 고농도로 결합된알긴산의 제조 방법 |
AP1919A (en) * | 2001-11-21 | 2008-11-13 | Eisai R&D Man Co Ltd | Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same |
US20050163846A1 (en) * | 2001-11-21 | 2005-07-28 | Eisai Co., Ltd. | Preparation composition containing acid-unstable physiologically active compound, and process for producing same |
US6663888B2 (en) | 2001-12-14 | 2003-12-16 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
CA2494716A1 (en) * | 2002-08-02 | 2004-02-19 | Ratiopharm Gmbh | Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
WO2004041195A2 (en) * | 2002-10-31 | 2004-05-21 | Supergen, Inc. | Pharmaceutical formulations targeting specific regions of the gastrointestinal tract |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
JP2006521366A (ja) * | 2003-03-28 | 2006-09-21 | シグモイド・バイオテクノロジーズ・リミテッド | シームレスマイクロカプセルを含む固形経口剤形 |
AR045062A1 (es) * | 2003-07-18 | 2005-10-12 | Santarus Inc | Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas |
PT1729797E (pt) | 2004-03-22 | 2008-12-17 | Solvay Pharm Gmbh | Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos |
BRPI0509135A (pt) * | 2004-03-26 | 2007-08-28 | Eisai R&D Man Co Ltd | composição farmacêutica de liberação controlada e método para produzir a mesma |
WO2005097082A1 (en) * | 2004-03-31 | 2005-10-20 | Bpsi Holdings, Inc. | Enteric coatings for orally ingestible substrates |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
CA2581816A1 (en) * | 2004-09-27 | 2006-04-06 | Sigmoid Biotechnologies Limited | Microcapsules comprising a methylxanthine and a corticosteroid |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
MX2007004741A (es) | 2004-10-21 | 2007-09-07 | Eurand Pharmaceuticals Ltd | Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles. |
BRPI0500586A (pt) * | 2005-02-21 | 2006-10-10 | Fundacao Oswaldo Cruz | composição farmacêutica, processo para preparar dita composição, uso da respectiva composição no tratamento da imunodeficiência causada por infecção pelo hiv e respectivo método de tratamento |
WO2006111980A2 (en) * | 2005-04-20 | 2006-10-26 | Ideal Cures Pvt. Ltd. | Pva based film coating and film coating compositions |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
AU2006274835B2 (en) | 2005-07-29 | 2012-05-24 | Abbott Laboratories Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
WO2007037259A1 (ja) * | 2005-09-29 | 2007-04-05 | Eisai R & D Management Co., Ltd. | 生体内での崩壊性を向上させたパルス製剤 |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
WO2008062320A2 (en) * | 2006-10-06 | 2008-05-29 | Eisai R&D Management Co., Ltd | Extended release formulations of a proton pump inhibitor |
SG186648A1 (en) | 2007-02-20 | 2013-01-30 | Aptalis Pharma Ltd | Stable digestive enzyme compositions |
CA2683409A1 (en) | 2007-04-04 | 2008-10-16 | Sigmoid Pharma Limited | A pharmaceutical composition of tacrolimus |
ES2963291T3 (es) * | 2007-04-26 | 2024-03-26 | Sublimity Therapeutics Ltd | Fabricación de múltiples minicápsulas |
US20100239665A1 (en) * | 2007-05-01 | 2010-09-23 | Ivan Coulter | Pharmaceutical nimodipine compositions |
CA2704826A1 (en) * | 2007-11-27 | 2009-06-04 | Ohara Pharmaceutical Co., Ltd. | Method for producing granulated preparation |
US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
US20110038933A1 (en) * | 2008-05-06 | 2011-02-17 | Dexcell Ltd. | Stable benzimidazole formulation |
US8840934B2 (en) * | 2009-01-02 | 2014-09-23 | Rainbow Pharmaceutical Sa | Uses of ammonium chloride |
EP2432455B1 (en) | 2009-05-18 | 2014-11-12 | Sigmoid Pharma Limited | Composition comprising oil drops |
CA2770570A1 (en) | 2009-08-12 | 2011-02-17 | Sigmoid Pharma Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
TWI471146B (zh) | 2009-12-02 | 2015-02-01 | Aptalis Pharma Ltd | 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物 |
US20110217426A1 (en) * | 2010-03-04 | 2011-09-08 | Perry Stephen C | Enteric coating composition |
JP6043929B2 (ja) | 2010-10-01 | 2016-12-14 | アラガン ファーマシューティカルズ インターナショナル リミテッド | 腸溶コーティングされた低力価パンクレリパーゼ製剤 |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
US20120328697A1 (en) * | 2011-06-01 | 2012-12-27 | Fmc Corporation | Controlled Release Solid Dose Forms |
US10953025B2 (en) * | 2011-07-14 | 2021-03-23 | Able Cerebral, Llc | Composition, device and method for delayed and sustained release of brain energy molecules |
CN103945832B (zh) * | 2011-07-14 | 2017-03-29 | 能脑有限责任公司 | 用于脑能量分子延迟释放和持续释放的组合物,装置及方法 |
EP2987499B1 (en) | 2011-08-08 | 2019-05-08 | Allergan Pharmaceuticals International Limited | Method for dissolution testing of solid compositions containing digestive enzymes |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
JP2016537387A (ja) | 2013-08-09 | 2016-12-01 | アラガン ファーマシューティカルズ インターナショナル リミテッド | 経腸投与に適した消化酵素組成物 |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
MX2014008314A (es) * | 2014-07-07 | 2016-01-06 | Andres Abelino Choza Romero | Procedimiento para mezclar sustancias, mediante nebulizacion. |
TWI535784B (zh) | 2014-08-26 | 2016-06-01 | 財團法人工業技術研究院 | 剪切增稠配方、及包含其之複合材料 |
PL3215127T3 (pl) | 2014-11-07 | 2021-05-17 | Sublimity Therapeutics Limited | Kompozycje zawierające cyklosporynę |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CZ2017315A3 (cs) | 2017-06-02 | 2018-12-12 | Zentiva, K.S. | Dávkovací jednotka s PPI (inhibitory protonové pumpy) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
JPS517116A (en) * | 1974-06-11 | 1976-01-21 | Shinetsu Chemical Co | Choyoseihifukuyakuzaino seizohoho |
CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
KR930000861B1 (ko) * | 1990-02-27 | 1993-02-08 | 한미약품공업 주식회사 | 오메프라졸 직장투여 조성물 |
US5232706A (en) * | 1990-12-31 | 1993-08-03 | Esteve Quimica, S.A. | Oral pharmaceutical preparation containing omeprazol |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
EP0519144B1 (en) * | 1991-06-21 | 1997-08-13 | Ilsan Ilac Ve Hammaddeleri Sanayi A.S. | New galenic process for omeprazole containing pellets |
FR2692146B1 (fr) * | 1992-06-16 | 1995-06-02 | Ethypharm Sa | Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention. |
EP0995447A1 (en) * | 1993-09-09 | 2000-04-26 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
-
1997
- 1997-07-31 ES ES009701816A patent/ES2137862B1/es not_active Expired - Fee Related
-
1998
- 1998-07-07 TW TW087110962A patent/TW533201B/zh not_active IP Right Cessation
- 1998-07-13 SK SK103-2000A patent/SK284892B6/sk unknown
- 1998-07-13 WO PCT/ES1998/000204 patent/WO1999006032A2/es active IP Right Grant
- 1998-07-13 RU RU2000104866/14A patent/RU2207114C2/ru not_active IP Right Cessation
- 1998-07-13 UA UA2000020750A patent/UA66800C2/uk unknown
- 1998-07-13 EP EP98932185A patent/EP1010423B1/en not_active Revoked
- 1998-07-13 JP JP2000504847A patent/JP3961217B2/ja not_active Expired - Lifetime
- 1998-07-13 NZ NZ502590A patent/NZ502590A/en not_active IP Right Cessation
- 1998-07-13 DK DK98932185T patent/DK1010423T3/da active
- 1998-07-13 DE DE69833490T patent/DE69833490T2/de not_active Expired - Lifetime
- 1998-07-13 CA CA002307037A patent/CA2307037C/en not_active Expired - Lifetime
- 1998-07-13 PT PT98932185T patent/PT1010423E/pt unknown
- 1998-07-13 AU AU82173/98A patent/AU751609B2/en not_active Expired
- 1998-07-13 HU HU0002524A patent/HU230635B1/hu unknown
- 1998-07-13 ES ES98932185T patent/ES2256943T4/es not_active Expired - Lifetime
- 1998-07-13 AT AT98932185T patent/ATE317688T1/de active
- 1998-07-13 TR TR2000/00264T patent/TR200000264T2/xx unknown
- 1998-07-13 PL PL338613A patent/PL192961B1/pl unknown
- 1998-07-13 KR KR1020007001023A patent/KR100591488B1/ko not_active IP Right Cessation
- 1998-07-13 IL IL13415898A patent/IL134158A/en not_active IP Right Cessation
- 1998-07-13 CZ CZ20000344A patent/CZ298700B6/cs not_active IP Right Cessation
- 1998-07-22 AR ARP980103576A patent/AR013242A1/es unknown
- 1998-07-23 HN HN1998000113A patent/HN1998000113A/es unknown
- 1998-07-23 PE PE1998000660A patent/PE105199A1/es not_active Application Discontinuation
- 1998-07-24 CR CR5826A patent/CR5826A/es not_active Application Discontinuation
- 1998-07-27 GT GT199800113A patent/GT199800113A/es unknown
- 1998-07-28 MY MYPI98003435A patent/MY121353A/en unknown
- 1998-07-30 PA PA19988456401A patent/PA8456401A1/es unknown
- 1998-07-31 ZA ZA986893A patent/ZA986893B/xx unknown
-
1999
- 1999-01-27 ES ES009900157A patent/ES2156699B1/es not_active Expired - Fee Related
-
2000
- 2000-01-26 US US09/491,624 patent/US20020098242A1/en not_active Abandoned
- 2000-01-27 NO NO20000435A patent/NO20000435L/no not_active Application Discontinuation
- 2000-01-31 HR HR20000053A patent/HRP20000053B1/xx not_active IP Right Cessation
- 2000-02-25 BG BG104193A patent/BG64967B1/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA986893B (en) | Oral pharmaceutical preparation which includes a compound of anti-ulcer activity and procedure for making same | |
HUP0103708A3 (en) | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method | |
EG24044A (en) | pharmaceutical formulation of omeprazole | |
IL131818A (en) | Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and solvates and their preparation | |
HUP9903407A3 (en) | Oral pharmaceutical preparation containing ibandronat | |
HUP9903308A3 (en) | Granuls for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug | |
EG21973A (en) | A new process for the preparation of a pharmacolgically active substance | |
IL191582A0 (en) | Polymorph of a pharmaceutical | |
HU9502918D0 (en) | Pharmaceutical composition of antihypertriglyceridemic activity | |
PL332249A1 (en) | Pharmaceutical microspheres of varproinic acid for oral administration | |
HUP9800573A3 (en) | Rapamycin formulations for oral administration and process for their preparation | |
PL307469A1 (en) | Preparation for oral administration | |
HU9502426D0 (en) | Compounds of pharmaceutical activity | |
ZA986320B (en) | A method for the preparation of tertiary amines a compound useful therefor and alpha-2-receptor active tetrahyd-roisoquinoline derivatives | |
ZA987538B (en) | A process for the preparation of solid oral dosage forms comprising alendronic acid | |
AU8885298A (en) | Sustained-release oral preparation | |
SI1103252T1 (en) | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method | |
AU5384798A (en) | Process for preparation of 4-deoxyerythromycins a and b | |
HU9700442D0 (en) | Compounds of pharmaceutical activity | |
TJ217R3 (en) | A method for the preparation of a substance having cholagogic and anti-inflammatory activity | |
HU9701917D0 (en) | New compound of medicinal activity | |
AU6224299A (en) | Pharmaceutical intermediate for the synthesis of fluoxetine and a process for the preparation thereof | |
TJ218R3 (en) | A method for the preparation of a substance having cholagogic activity | |
TJ213R3 (en) | A method for the preparation of a substance having immunostimulate activity | |
GB9408369D0 (en) | Oral administration of protein drugs |